Compare GoPro Inc (GPRO) vs Merck & Co., Inc. (MRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GoPro Inc vs Merck & Co., Inc. — how do they compare? GoPro Inc trades at $1.19 (market cap $243.50M), while Merck & Co., Inc. trades at $146.31 (market cap $351.28B). The key difference: Merck & Co., Inc. is far larger — about 1442.6× GoPro Inc's market cap, and Merck & Co., Inc. pays a 2.39% dividend while GoPro Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold GoPro Inc for 45 Days and Merck & Co., Inc. for 98 Days on average.
| GPRO | MRK | |
|---|---|---|
Market Cap | $243.50M | $351.28B |
Volume | 11,527,160 | 7,969,665 |
Sector | Technology | Health |
52-Week High | $2.35 | $156.43 |
52-Week Low | $0.58 | $82.49 |
Typical Hold Time | 45 Days | 98 Days |
Enterprise Value | $302.28M | $398.04B |
Dividend Yield | — | 2.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GoPro (GPRO) trades at $1.20, down 1.64% with a volatile trading pattern following recent merger announcements. The stock shows bullish technical signals despite negative fundamental metrics including a -28.52% net income margin and -497.15% ROE. Recent developments include a $285 million merger agreement with Starman Optical and significant retail investor interest from influencer Markiplier's 8.5% stake acquisition.
The proposed merger at $1.14 per share creates a potential exit opportunity, though current trading above this level suggests market optimism about deal terms. However, persistent negative cash flows, declining revenues, and shareholder litigation regarding deal fairness present substantial risks. The company's pivot into AI data centers offers growth potential but execution uncertainty remains high.
Merck (MRK) trades at $144.96, up 1.52% today, with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with a 72.97% gross margin and 28.07% net income margin for 2025, though its P/E ratio of 113.9 indicates high valuation. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, reflecting strategic growth initiatives amid competitive pressures.
The outlook is mixed: analyst consensus is bullish with a $158.78 price target, but technical indicators and a high P/E suggest near-term caution. Key risks include integration challenges from acquisitions and macroeconomic headwinds affecting pharmaceutical R&D investment. Revenue growth and pipeline execution remain critical for sustained upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GoPro Inc
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →
